• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3

CATEGORIES

  • 17
  • 13
  • 12
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

5
5
9
53

PUBLISHED

1
7
29
53

PRODUCT TYPE

48
5

Search "Athersys, Inc.-Therapeutic Competitors" returned 53 results.

PRODUCT TITLE

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

June 2014
FROM

Global Stem Cell and Advanced Technologies Market

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies The benefits of stem cell therapy are attracting an increasing number of patients The product...

November 2009
FROM

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D

GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government...

November 2011
FROM

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014’, provides...

May 2014
FROM

Interleukin Genetics, Inc.

A textual analysis of the financial results for Interleukin Genetics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

May 2015
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the...

October 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015’, provides an overview of the...

January 2015
FROM
Bulk Paclitaxel - Global Strategic Business Report Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

This report analyzes the worldwide markets for Bulk Paclitaxel in kilograms and US$ Million. The report provides separate comprehensive analytics for the US, and Rest of World. Annual forecasts are...

October 2008
FROM

Myelodysplastic Syndrome - Pipeline Review, H1 2014

Myelodysplastic Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Myelodysplastic Syndrome’s therapeutic...

February 2014
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014’, provides an overview of the Hematopoietic Stem...

October 2014
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014’, provides an overview of the...

April 2014
FROM

Ischemic Stroke - Pipeline Review, H1 2015

Ischemic Stroke - Pipeline Review, H1 2015 Summary: This, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides...

March 2015
FROM

Ischemia - Pipeline Review, H2 2014

Ischemia - Pipeline Review, H2 2014 Summary This, ‘Ischemia - Pipeline Review, H2 2014’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Spinal Cord Injury - Pipeline Review, H1 2014

Spinal Cord Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Spinal Cord Injury - Pipeline Review, H1 2014’, provides an overview of the Spinal Cord Injury’s therapeutic pipeline. This...

February 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

March 2015
FROM

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies,...

December 2012
FROM

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

March 2015
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H1 2014

Traumatic Brain Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic...

April 2014
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office